With COVID-19 shots from Pfizer-BioNTech and Moderna Inc. both available in Japan’s booster campaign, many may be wondering how the two shots compare.
As the booster rollout speeds up, some are also wondering if they should stick with the same kind of shot they got in the first round or go with a cross-vaccination: two Pfizers and a Moderna, or two Modernas and a Pfizer.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
PHOTO GALLERY (CLICK TO ENLARGE)
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.